Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Pays Affymetrix $2M in Stock As Part of Dx Deal

NEW YORK (GenomeWeb News) - Epigenomics yesterday paid Affymetrix €1.6 million ($2 million) worth of stock as part of the upfront payments the firms agreed to under their diagnostic alliance announced in June, the company said today.
As part of the deal, Epigenomics issued 304,791 novel non par value bearer shares valued at €5.22 each. After registration, the value of Epigenomics' outstanding common shares will increase to €16.7 million from €16.4 million.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.